Search clinical trials for: platinum derivatives

Total 1633 results

University of Michigan Rogel Cancer Center

Completed

Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC

Extensive-Stage Small Cell Lung Cancer

United States
Taipei Veterans General Hospital, Taiwan
National Taiwan University Hospital; China Medical University Hospital; Tri-Service... and other collaborators

Unknown

Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy

NSCLC

Taiwan
AGO Study Group
Philipps University Marburg Medical Center; HSK Reasearch GmbH Wiesbaden

Completed

Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor

Platinum Refractory Epithelial Ovarian Cancer | Primary Cancer of the Peritoneum | Cancer of the Fallopian Tube

Germany
University of British Columbia

Completed

Study to See if Microcoil Insertion Reduces the Rate of Open Thoracotomy for Removal of Lung Nodules

Lung Cancer

Canada
CSL Behring

Completed

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

Blood Coagulation Disorders | Acute Major Bleeding

United States, Belarus, Bulgaria, Romania, Russian Federation, Ukraine
Seoul National University Bundang Hospital

Completed

Rotational Thromboelstometry (ROTEM) change_colloid_total Hip Replacement Arthroplasty

Avascular Necrosis of Hip | Total Hip Replacement Arthroplasty

Korea, Republic of
National University Hospital, Singapore

Terminated

A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)

Cancer

Singapore
New Mexico Cancer Care Alliance
Celgene Corporation

Terminated

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer

Ovarian Cancer | Epithelial Ovarian Cancer | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma

United States
Leiden University Medical Center
University Medical Center Groningen

Completed

Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer (CHIP)

Recurrent Ovarian Cancer

Netherlands
Nordic Society of Gynaecological Oncology - Clinical...

Completed

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

Ovarian Epithelial Cancer Recurrent

Denmark, Finland, Norway
Boehringer Ingelheim

Completed

6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab

Breast Neoplasms

United States, Brazil, Colombia, Peru
Emory University
Genentech, Inc.

Withdrawn

Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Fallopian Tube Neoplasms | Ovarian Cancer | Primary Peritoneal
Medical Research Council

Completed

Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United Kingdom
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring Systems (SPACE2)

Diabetes Mellitus

Netherlands
Xinjiang Medical University

Unknown

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

Non-small Cell Lung Cancer

China
Telik

Terminated

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer (ASSIST-5)

Ovarian Neoplasms

United States, United Kingdom, Belgium, Brazil
Accelerated Community Oncology Research Network

Completed

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Non-Small Cell Lung Cancer

United States
Hospices Civils de Lyon

Completed

Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1 (EHOSS-1)

Septic Shock
University of California, San Francisco
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms

Arteriovenous Malformations | Aneurysms

United States
Regional Hospital Holstebro

Completed

Hydroxyethyl Starch and Renal Function After Radical Prostatectomy (VORA)

Prostate Cancer

Denmark
Clavis Pharma

Completed

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Ovarian Cancer

Belgium, Italy
Johnson & Johnson Pharmaceutical Research & Development...
Centocor Ortho Biotech Services, L.L.C.

Completed

A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

United States
M.D. Anderson Cancer Center

Completed

Gleevec Study for Patients With Ovarian Cancer

Ovarian Cancer

United States
WiSP Wissenschaftlicher Service Pharma GmbH
ClinAssess GmbH

Unknown

Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer (PROVE)

Ovarian Cancer

Germany
Sangart

Completed

Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty

Ischemia | Hypotension

Netherlands, Belgium, Czech Republic, Sweden, Poland, United Kingdom
Sangart

Completed

Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty

Ischemia | Hypotension

Netherlands, Belgium, Sweden, Czech Republic, Poland
Sangart

Completed

Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

Vascular Disease | Critical Lower Limb Ischemia

Sweden
University of Birmingham

Unknown

Finasteride, Dutasteride and Insulin Action (FIND-IT)

Healthy Volunteers

United Kingdom
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Lung Cancer

Canada, United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy

Lung Cancer

United States
National Cancer Institute (NCI)

Completed

Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
Regional Hospital Holstebro

Completed

Hydroxyethyl Starch and Renal Function After Hip Replacement Surgery (VOHO)

Osteoarthritis

Denmark
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Norway
Wuhan University

Unknown

A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer

Recurrent Ovarian Cancer

China
Samsung Medical Center

Completed

Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma

Metastatic Esophageal Squamous Cell Carcinoma
Samsung Medical Center

Completed

Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer

Advanced Gastric Cancer

Korea, Republic of
University of Mississippi Medical Center

Completed

Tocolysis for Preterm Labor

Preterm Labor

United States
EGEN, Inc.

Completed

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Ovarian Neoplasms

United States
Sanofi

Completed

AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor

Neoplasms

France, Italy, Switzerland
University of Roma La Sapienza

Unknown

Effects of DES Platforms on Markers of Endothelial Damage and Inflammation (PLATFORM)

Coronary Artery Disease

Italy
Astellas Pharma Inc

Completed

Special Drug Use-Results Survey of Lipitor Tablets (ALWAYS)

Hypercholesterolemia

Japan
University Hospital, Bonn

Unknown

Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer (HIPEC ROC I)

Ovarian Cancer

Germany
Hollister Wound Care LLC

Terminated

Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers

Infection | Venous Ulcer

United States
Dijklander Ziekenhuis

Unknown

Pilot Study on the Effectiveness of a TAP-block for Inguinal Hernia Repair

Hernia Inguinal

Netherlands
Maisonneuve-Rosemont Hospital
Université de Montréal

Unknown

ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia

Hypotension | Cesarean Section | Spinal Anesthesia | Fluid Therapy | Obstetric Anesthesia

Canada
Centre Francois Baclesse
GRECAN

Completed

Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors (ABT737 exvivo)

Ovarian Cancer

France
Boston Scientific Corporation

Unknown

A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion (PLATINUM China)

Coronary Artery Disease | Atherosclerosis

China
AstraZeneca

Withdrawn

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (IMAC/Herbst)

Non-Small-Cell Lung Carcinoma

3

Subscribe